Literature DB >> 24329397

Severe renal failure and hyperammonemia in a newborn with propionic acidemia: effects of treatment on the clinical course.

Ciğdem Seher Kasapkara1, Melek Akar, Zeynep Nagehan Yürük Yıldırım, Heybet Tüzün, Berat Kanar, Mehmet Nuri Ozbek.   

Abstract

Neonatal-onset propionic acidemia (PA), the most common form, is characterized by poor feeding, vomiting, and somnolence in the first days of life in a previously healthy infant, followed by lethargy, seizures, and can progress to coma if not identified and treated appropriately. It is frequently accompanied by metabolic acidosis with anion gap, ketonuria, hypoglycemia, hyperammonemia, and cytopenias. PA is caused by deficiency of propionyl-CoA carboxylase (PCC), the enzyme that catalyzes the conversion of propionyl-CoA to methylmalonyl-CoA. Herein, we report a case of 3-day-old neonate with PA presented with acute renal failure and metabolic acidosis was effectively treated by peritoneal dialysis and conventional methods.

Entities:  

Mesh:

Year:  2013        PMID: 24329397     DOI: 10.3109/0886022X.2013.865484

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  3 in total

1.  Disruption of mitochondrial functions involving mitochondrial permeability transition pore opening caused by maleic acid in rat kidney.

Authors:  Ana Cristina Roginski; Ângela Beatris Zemniaçak; Rafael Aguiar Marschner; Simone Magagnin Wajner; Rafael Teixeira Ribeiro; Moacir Wajner; Alexandre Umpierrez Amaral
Journal:  J Bioenerg Biomembr       Date:  2022-07-29       Impact factor: 3.853

Review 2.  Methylmalonic and propionic acidemias: clinical management update.

Authors:  Jamie L Fraser; Charles P Venditti
Journal:  Curr Opin Pediatr       Date:  2016-12       Impact factor: 2.856

3.  Antenatal nephromegaly and propionic acidemia: a case report.

Authors:  Ségolène Bernheim; Georges Deschênes; Manuel Schiff; Isabelle Cussenot; Olivier Niel
Journal:  BMC Nephrol       Date:  2017-03-30       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.